- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07780617
Comparison of Simplified Acute Physiology Score (SAPS II) , Sequential Organ Failure Assessment (SOFA) and Acute Physiology and Chronic Health Evaluation) APACHE II Scoring Systems for Predicting Mortality of Critically Ill Patients Admitted in a Tertiary Hospital Intensive Care Unit. (SAPS II SOFA)
August 19, 2026 updated by: Ashmita Paudel, Tribhuvan University Teaching Hospital, Institute Of Medicine.
Comparison of SAPS II, SOFA and APACHE II Scoring Systems for Predicting Mortality of Critically Ill Patients Admitted in a Tertiary Hospital Intensive Care Unit
This is a descriptive analytical prospective study to compare the performance of SOFA score, SAPSII score and APACHE II score in ICU mortality prediction.
Study Overview
Status
Completed
Conditions
Detailed Description
All the eligible patients admitted to the ICU are enrolled in the study.
For each enrolled patient SAPS II, SOFA and APACHE II score will be calculated and these patient will be followed till they are in ICU stay.
A comparison of predictive performance of each score will be done for mortality in the ICU.
Study Type
Observational
Enrollment (Actual)
201
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Bagmati
-
Bharatpur, Bagmati, Nepal
- Bharatpur Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Admitted to ICU
Description
Inclusion Criteria:
18 years and above Admitted to ICU with expected stay of more or equal to 24 hours
Exclusion Criteria:
- whose consent could not be obtained
- treatment limitation order in form of DNI/DNR, withdrawal of life support
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
mortality
Time Frame: Through study period on average 1 year
|
ICU mortality
|
Through study period on average 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Ashmita Paudel, Bharatpur Eye Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2025
Primary Completion (Actual)
December 30, 2025
Study Completion (Actual)
January 30, 2026
Study Registration Dates
First Submitted
August 12, 2026
First Submitted That Met QC Criteria
August 19, 2026
First Posted (Actual)
August 21, 2026
Study Record Updates
Last Update Posted (Actual)
August 21, 2026
Last Update Submitted That Met QC Criteria
August 19, 2026
Last Verified
August 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- 081/82-067
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.